Acompanhe as Notícias da Recifes

Advances in research have identified biomarker tests that make it possible to detect signs of neurodegenerative conditions such as Alzheimer's disease years before symptoms appear, creating new opportunities for earlier intervention—and new questions for clinicians, patients and

Artificial intelligence is often presented as a threat to professional work, raising fears about deskilling, job displacement and the loss of human judgment. But new research involving health care professionals using AI in cancer treatment suggests a more nuanced story. The study

A large real-world clinical trial has found that a generative AI-powered support tool used to support frontline clinicians was safe and improved the quality of clinical decision-making, but did not significantly change short-term patient outcomes.

Researchers at the Nuffield Department of Primary Care Health Sciences, University of Oxford, have developed a new calculator that estimates a person's risk of developing serious muscle disorders from statins. The tool could help patients and clinicians make more informed decisio

Cedars-Sinai Health Sciences University investigators developed an AI-based model that can identify hospitalized patients at risk of low blood sugar up to 24 hours before the condition occurs. The long short-term memory (LSTM) model, described in npj Digital Medicine, could help

New research suggests that low handgrip strength alone is not a reliable predictor of increased prostate cancer risk among older men. The relationship between low handgrip strength (HGS) and prostate cancer has long remained uncertain in the scientific literature. When clinicians

Lyme disease can be easiest to treat in its earliest stages, but current tests often miss infections during that critical window and cannot tell whether bacteria are still present or were cleared years ago. New research led by Tufts University School of Medicine suggests that a g

At its heart, health care is a conversation. A patient needs to explain what is wrong. They need to understand their options. They need to make decisions about their own care. Clinicians need clear information, too. They need to understand symptoms, explain risks, discuss treatme

One of the uncomfortable truths about multiple sclerosis is that the part of the brain likely to reveal the most about the disease and how a patient will be affected has been mostly invisible to clinicians.

Women with cancer may not have the same chance of cure or quality of life as men—yet fewer than 2% of Australian cancer clinical trials report results separately for men and women. Women are also more likely to experience severe side effects from cancer treatment, including immun

Early detection and treatment of congenital cerebral ventriculomegaly (CCV)—when a fetus's fluid-filled brain ventricles swell due to a condition called hydrocephalus—can help clinicians prevent developmental or neurological disabilities in affected infants. New research led by i

A study led by biomedical scientist Erica Heinrich at the University of California, Riverside, highlights a critical gap in how clinicians detect and treat breathing distress (dyspnea), particularly in patients on ventilators. The research is published in the journal Respiratory